Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction

Abstract Despite widespread preclinical success, mesenchymal stromal cell (MSC) therapy has not reached consistent pivotal clinical endpoints in primary indications of autoinflammatory diseases. Numerous studies aim to uncover specific mechanisms of action towards better control of therapy using in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matthew Li, Danika Khong, Ling-Yee Chin, Amy Singleton, Biju Parekkadan
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/782a48001def412f8bfcf8ee08491cdc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:782a48001def412f8bfcf8ee08491cdc
record_format dspace
spelling oai:doaj.org-article:782a48001def412f8bfcf8ee08491cdc2021-12-02T12:32:35ZTherapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction10.1038/s41598-018-24971-22045-2322https://doaj.org/article/782a48001def412f8bfcf8ee08491cdc2018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-24971-2https://doaj.org/toc/2045-2322Abstract Despite widespread preclinical success, mesenchymal stromal cell (MSC) therapy has not reached consistent pivotal clinical endpoints in primary indications of autoinflammatory diseases. Numerous studies aim to uncover specific mechanisms of action towards better control of therapy using in vitro immunomodulation assays. However, many of these immunomodulation assays are imperfectly designed to accurately recapitulate microenvironment conditions where MSCs act. To increase our understanding of MSC efficacy, we herein conduct a systems level microenvironment approach to define compartmental features that can influence the delivery of MSCs’ immunomodulatory effect in vitro in a more quantitative manner than ever before. Using this approach, we notably uncover an improved MSC quantification method with predictive cross-study applicability and unveil the key importance of system volume, time exposure to MSCs, and cross-communication between MSC and T cell populations to realize full therapeutic effect. The application of these compartmental analysis can improve our understanding of MSC mechanism(s) of action and further lead to administration methods that deliver MSCs within a compartment for predictable potency.Matthew LiDanika KhongLing-Yee ChinAmy SingletonBiju ParekkadanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-12 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Matthew Li
Danika Khong
Ling-Yee Chin
Amy Singleton
Biju Parekkadan
Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction
description Abstract Despite widespread preclinical success, mesenchymal stromal cell (MSC) therapy has not reached consistent pivotal clinical endpoints in primary indications of autoinflammatory diseases. Numerous studies aim to uncover specific mechanisms of action towards better control of therapy using in vitro immunomodulation assays. However, many of these immunomodulation assays are imperfectly designed to accurately recapitulate microenvironment conditions where MSCs act. To increase our understanding of MSC efficacy, we herein conduct a systems level microenvironment approach to define compartmental features that can influence the delivery of MSCs’ immunomodulatory effect in vitro in a more quantitative manner than ever before. Using this approach, we notably uncover an improved MSC quantification method with predictive cross-study applicability and unveil the key importance of system volume, time exposure to MSCs, and cross-communication between MSC and T cell populations to realize full therapeutic effect. The application of these compartmental analysis can improve our understanding of MSC mechanism(s) of action and further lead to administration methods that deliver MSCs within a compartment for predictable potency.
format article
author Matthew Li
Danika Khong
Ling-Yee Chin
Amy Singleton
Biju Parekkadan
author_facet Matthew Li
Danika Khong
Ling-Yee Chin
Amy Singleton
Biju Parekkadan
author_sort Matthew Li
title Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction
title_short Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction
title_full Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction
title_fullStr Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction
title_full_unstemmed Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction
title_sort therapeutic delivery specifications identified through compartmental analysis of a mesenchymal stromal cell-immune reaction
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/782a48001def412f8bfcf8ee08491cdc
work_keys_str_mv AT matthewli therapeuticdeliveryspecificationsidentifiedthroughcompartmentalanalysisofamesenchymalstromalcellimmunereaction
AT danikakhong therapeuticdeliveryspecificationsidentifiedthroughcompartmentalanalysisofamesenchymalstromalcellimmunereaction
AT lingyeechin therapeuticdeliveryspecificationsidentifiedthroughcompartmentalanalysisofamesenchymalstromalcellimmunereaction
AT amysingleton therapeuticdeliveryspecificationsidentifiedthroughcompartmentalanalysisofamesenchymalstromalcellimmunereaction
AT bijuparekkadan therapeuticdeliveryspecificationsidentifiedthroughcompartmentalanalysisofamesenchymalstromalcellimmunereaction
_version_ 1718394042158415872